UnicoCell Biomed Co., Ltd. (TPE:6794)

UnicoCell Biomed Statistics

Total Valuation

TPE:6794 has a market cap or net worth of TWD 5.09 billion. The enterprise value is 4.41 billion.

Market Cap	5.09B
Enterprise Value	4.41B

Important Dates

The last earnings date was Wednesday, February 25, 2026.

Earnings Date	Feb 25, 2026
Ex-Dividend Date	n/a

Share Statistics

TPE:6794 has 63.64 million shares outstanding. The number of shares has increased by 6.14% in one year.

Current Share Class	63.64M
Shares Outstanding	63.64M
Shares Change (YoY)	+6.14%
Shares Change (QoQ)	+4.20%
Owned by Insiders (%)	15.17%
Owned by Institutions (%)	n/a
Float	23.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	169.12
PB Ratio	5.88
P/TBV Ratio	5.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-38.37
EV / Sales	146.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-45.52

Financial Position

The company has a current ratio of 37.98, with a Debt / Equity ratio of 0.07.

Current Ratio	37.98
Quick Ratio	37.09
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	-0.64
Interest Coverage	-97.30

Financial Efficiency

Return on equity (ROE) is -14.82% and return on invested capital (ROIC) is -9.69%.

Return on Equity (ROE)	-14.82%
Return on Assets (ROA)	-9.45%
Return on Invested Capital (ROIC)	-9.69%
Return on Capital Employed (ROCE)	-14.08%
Weighted Average Cost of Capital (WACC)	2.19%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	27
Asset Turnover	0.03
Inventory Turnover	1.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +13.15% in the last 52 weeks. The beta is -0.37, so TPE:6794's price volatility has been lower than the market average.

Beta (5Y)	-0.37
52-Week Price Change	+13.15%
50-Day Moving Average	86.11
200-Day Moving Average	76.27
Relative Strength Index (RSI)	40.48
Average Volume (20 Days)	88,162

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPE:6794 had revenue of TWD 30.10 million and -114.84 million in losses. Loss per share was -1.89.

Revenue	30.10M
Gross Profit	18.98M
Operating Income	-130.28M
Pretax Income	-114.84M
Net Income	-114.84M
EBITDA	-116.71M
EBIT	-130.28M
Loss Per Share	-1.89

Balance Sheet

The company has 746.27 million in cash and 62.02 million in debt, with a net cash position of 684.25 million or 10.75 per share.

Cash & Cash Equivalents	746.27M
Total Debt	62.02M
Net Cash	684.25M
Net Cash Per Share	10.75
Equity (Book Value)	865.44M
Book Value Per Share	13.60
Working Capital	766.43M

Cash Flow

In the last 12 months, operating cash flow was -91.31 million and capital expenditures -5.50 million, giving a free cash flow of -96.81 million.

Operating Cash Flow	-91.31M
Capital Expenditures	-5.50M
Depreciation & Amortization	13.57M
Net Borrowing	-6.22M
Free Cash Flow	-96.81M
FCF Per Share	-1.52

Margins

Gross Margin	63.04%
Operating Margin	-432.77%
Pretax Margin	-381.48%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPE:6794 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.14%
Shareholder Yield	-6.14%
Earnings Yield	-2.26%
FCF Yield	-1.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPE:6794 has an Altman Z-Score of 31.31 and a Piotroski F-Score of 2.

Altman Z-Score	31.31
Piotroski F-Score	2